(Stroke. 1999;30:1687-1694.)
© 1999 American Heart Association, Inc.
Original Contributions |
From Clinica Neurologica, Dipartimento di Neuroscienze, Università Tor Vergata (P.C., G.A.M., A.P., G.B.), and IRCCS Ospedale Santa Lucia (P.C., G.B.), Rome, and Dipartimento di Neuroscienze, Università Federico II (S.A.), Naples, Italy.
Correspondence to Paolo Calabresi, Clinica Neurologica, Dipartimento di Neuroscienze, Università "Tor Vergata," via di Tor Vergata 135, 00133, Rome, Italy. E-mail calabre{at}uniroma2.it
| Abstract |
|---|
|
|
|---|
MethodsWe investigated the effects of bepridil and 3',4'-dichlorobenzamil (DCB), 2 blockers of the Na+/Ca2+ exchanger, in rat striatal spiny neurons by utilizing intracellular recordings in brain slice preparations to compare the action of these drugs on the membrane potential changes induced either by oxygen and glucose deprivation (OGD) or by excitatory amino acids (EAAs).
ResultsBepridil (3 to 100 µmol/L) and DCB (3 to 100 µmol/L) caused a dose-dependent enhancement of the OGD-induced depolarization measured in striatal neurons. The EC50 values for these effects were 31 µmol/L and 29 µmol/L, respectively. At these concentrations neither bepridil nor DCB altered the resting membrane properties of the recorded cells (membrane potential, input resistance, and current-voltage relationship). The effects of bepridil and DCB on the OGD-induced membrane depolarization persisted in the presence of D-2-amino-5-phosphonovalerate (50 µmol/L) plus 6-cyano-7-nitroquinoxaline-2,3-dione (20 µmol/L), which suggests that they were not mediated by an enhanced release of EAAs. Neither tetrodotoxin (1 µmol/L) nor nifedipine (10 µmol/L) affect the actions of these 2 blockers of the Na+/Ca2+ exchanger, which indicates that voltage-dependent Na+ channels and L-type Ca2+ channels were not involved in the enhancement of the OGD-induced depolarization. Conversely, the OGD-induced membrane depolarization was not altered by 5-(N,N-hexamethylene) amiloride (1 to 3 µmol/L), an inhibitor of the Na+/H+ exchanger, which suggests that this antiporter did not play a prominent role in the OGD-induced membrane depolarization recorded from striatal neurons. Bepridil (3 to 100 µmol/L) and DCB (3 to 100 µmol/L) did not modify the amplitude of the excitatory postsynaptic potentials evoked by cortical stimulation. Moreover, these blockers did not affect membrane depolarizations caused by brief applications of glutamate (0.3 to 1 mmol/L), AMPA (0.3 to 1 µmol/L), and NMDA (10 to 30 µmol/L).
ConclusionsThese results provide pharmacological evidence that the activation of the Na+/Ca2+ exchanger exerts a protective role during the early phase of OGD in striatal neurons, although it does not shape the amplitude and the duration of the electrophysiological responses of these cells to EAA.
Key Words: bepridil 3,4-dichlorobenzamil excitatory amino acids ischemia sodium-hydrogen antiporter synaptic transmission rats
| Introduction |
|---|
|
|
|---|
In this work, therefore, we sought to further elucidate the possible modulatory role of Na+/Ca2+ exchanger during combined oxygen and glucose deprivation (OGD) and during the action of EAAs in striatal spiny neurons, a neuronal subtype that is particularly vulnerable both to energy deprivation and excitotoxicity.4 16 17 18 For this reason, we have tested the effects of bepridil12 14 19 20 21 and 3',4'-dichlorobenzamil (DCB),22 23 24 25 2 inhibitors of this exchanger, on the membrane depolarization induced by OGD in striatal spiny neurons intracellularly recorded from a brain slice preparation. Thus, we have compared these effects with those observed after blockade of Na+/Ca2+ exchanger during membrane depolarizations caused either by endogenous glutamate or by exogenous applications of EAA agonists.
| Materials and Methods |
|---|
|
|
|---|
Recording Technique
In most of the experiments the intracellular recording
electrodes were filled with 2 mol/L KCl (30 to 60 M
). An Axoclamp 2A
amplifier (Axon Instruments) was used for intracellular
recordings. Traces were displayed on an oscilloscope and stored
on a digital system. For synaptic stimulation, bipolar electrodes were
used. These stimulating electrodes were located either in the cortical
areas close to the recording electrode or in the white matter
between the cortex and the striatum to activate corticostriatal
fibers. In some experiments biocytin (Sigma) was used in the
intracellular electrode to stain the neurons. In these cases, biocytin
at concentrations of 2% to 4% was added to a 0.5 mol/L-KCl pipette
solution. Slices containing neurons stained with biocytin were fixed in
paraformaldehyde (in 0.1 mol/L phosphate buffer at pH
7.4) overnight and processed according to published
protocols.27
Data Analysis and Drug Applications
Quantitative data on changes of membrane depolarization were
usually expressed as a percentage of the control value. Values given in
the text and in the figures are mean±SEM of changes in the respective
cell populations. The Student t test (for paired and
unpaired observations) was used to compare the means. The
characteristics of action potentials and of current-voltage curves in
different experimental conditions were studied with use of a fast chart
recorder and a digital system (Nicolet System 400; Benchtop
Waveform Acquisition System, Sekonic). To calculate the area of the
depolarization caused either by the application of the ischemic
medium or by the application of EAAs, data were displayed on a
high-gain strip-chart recorder (Gould RS 3400) and the area was
calculated by the use of a digital planimeter. Responses that did not
show any tendency to recovery after the offset of OGD or EAA
application were discarded from the statistics. Drugs were administered
by dissolving them to the desired final concentration in the saline and
by switching the perfusion from control saline to drug-containing
saline. 6-Cyano-7-nitroquinoxaline-2,3-dione (CNQX) was from Tocris.
D-2-Amino-5-phosphonovalerate (D-APV), bepridil,
and tetrodotoxin (TTX) were from Sigma. Nifedipine was from
RBI. DCB and 5-(N,N-hexamethylene)
amiloride were from E.J. Cragoe, Jr (Nacogdoches, Tex).
| Results |
|---|
|
|
|---|
) when measured at the resting potentials from the amplitude of
small (<10 mV) hyperpolarizing electrotonic pulses, action potentials
of short duration (1.1±0.3 ms), and high amplitude (102±4 mV). They
were silent at rest and showed membrane rectification and tonic firing
activity during depolarizing current pulses. In 22 of the 81
recorded spiny neurons, the
electrophysiological identification was
confirmed by a morphological analysis obtained by use of
biocytin staining (data not shown).
Effect of Bepridil and DCB on the OGD-Induced Membrane
Depolarization
OGD induced a membrane depolarization in all the
recorded cells. The amplitude and the duration of the OGD-induced
membrane depolarization was dependent on the time of exposure to the
ischemic medium.29 As we have previously reported
for hypoxia4 and aglycemia,17 this
electrophysiological event was associated
to a decreased input resistance (n=10, data not shown).29
Moreover, we found that the time course of the ischemic
depolarization was much faster than those observed for hypoxia
and aglycemia alone.4 17 In fact, a brief period (90
seconds) of OGD produced a significant membrane depolarization in the
large majority of the recorded neurons (65 of 70 cells) whereas
similar periods of aglycemia and hypoxia alone induced either
no effect or much smaller changes of the membrane potential. In the
remaining 5 striatal neurons, longer periods (2 to 3 minutes) of OGD
were required to produce the membrane depolarization. To study the
possible modulatory role of the
Na+/Ca2+ exchanger on the
ischemic depolarization, we applied bepridil, a blocker of this
exchanger, 5 to 10 minutes before the brief ischemic exposure.
In all the experiments using either bepridil or other pharmacological
blockers, at least 2 control ischemic responses were obtained.
Only neurons showing constant control responses to OGD were considered
for further pharmacological analysis. Bepridil enhanced in a
dose-dependent manner (10 to 100 µmol/L, n=30) the OGD-induced
membrane depolarization with an EC50 of 31
µmol/L (Figure 1
). We also tested
whether DCB, a more specific blocker of the
Na+/Ca2+ exchanger, could
mimic the electrophysiological effect
obtained with bepridil. As shown in Figure 2
, DCB also increased in a dose-dependent
manner (10 to 100 µmol/L, n=25) the ischemic
depolarization with an EC50 of 29 µmol/L.
We also investigated the possibility that bepridil and DCB altered the
resting membrane properties of the recorded cells. At the doses
used in the present study, neither bepridil (n=30) nor DCB (n=25)
altered resting membrane potential, input resistance, and
current-voltage relationship in the subthreshold range (Figure 3
).
|
|
|
Effects of Bepridil and DCB Are Not Affected by
Antagonists of Excitatory Amino Acids, TTX, and
Ca2+ Channel Blockers
It has been reported that bepridil might produce effects other
than the blockade of the
Na+/Ca2+ exchanger. In
particular, it has recently been shown30 that bepridil
modulates NMDA currents in rat hippocampal neurons. Moreover, bepridil
is able to enhance the release of EAAs induced by energy
deprivation in hippocampal slices.7 For this
reason, it was crucial to test (1) the possible involvement of an
increased release of EAAs in the facilitatory effects of bepridil and
DCB on the OGD-induced membrane depolarization and (2) the
possibility that the pharmacological effects of these blockers were due
to a postsynaptic modulation of neuronal responses to EAAs released
during OGD. To address these issues, we incubated the slices in the
presence of 50 µmol/L APV plus 20 µmol/L CNQX, which
antagonize NMDA- and AMPA-like glutamate receptors, respectively. This
pharmacological treatment affected neither the membrane depolarization
induced by OGD (n=7, data not shown) nor the facilitatory action of
bepridil (n=4, Figures 4A
and 5
) and DCB (n=4, Figure 5
).
Bepridil may also have a direct effect on voltage-dependent
Na+ channels. Thus, we investigated whether TTX,
a Na+ channel blocker, affected the effects of
bepridil and DCB. TTX did not alter the OGD-induced membrane
depolarization (n=3, data not shown) or the pharmacological effects on
OGD produced by bepridil (n=4, Figures 4B
and 5
) and DCB
(n=4, Figure 5
). Furthermore, because it has been reported that
bepridil modulates L-type Ca2+
channels, we studied the pharmacological action of bepridil and DCB in
the presence of 10 µmol/L nifedipine, a blocker of
L-type Ca2+ channels. Also, this
channel blocker failed to affect the OGD-induced depolarization (n=3,
data not shown) and the actions of bepridil (n=4, Figures 4C
and 5
) and DCB (n=4, Figure 5
).
|
|
Lack of Effect of Bepridil and DCB on Responses to EAAs
To further investigate the possible interaction between the
activity of the Na+/Ca2+
exchanger and the electrophysiological
effects of EAAs on striatal neurons both at presynaptic and
postsynaptic sites, we studied the effect of bepridil and DCB in
various experimental conditions. First, we measured the effect of these
blockers on the amplitude of EPSPs evoked by cortical stimulation.
Neither bepridil (30 µmol/L, Figures 6A
and E) nor DCB (30 µmol/L, data
not shown) affected the amplitude of these synaptic potentials. Then,
we tested a possible action of these 2 drugs on the membrane
depolarizations induced by brief applications of glutamate (1
mmol/L, 10 to 20 seconds), AMPA (0.3 to 1 µmol/L, 30 to 60
seconds), and NMDA (10 to 30 µmol/L, 30 to 60 seconds). Neither
bepridil (30 µmol/L, Figures 6B
, C, D, and E) nor DCB
(30 µmol/L, data not shown) were able to modify these membrane
responses.
|
Lack of Effect of HMA on the OGD-Induced Membrane
Depolarization
It has been suggested that intracellular acidification which
occurs during ischemia activates the
Na+/H+ exchanger, resulting
in Na+ loading. Pharmacological inhibition of the
Na+/H+ exchanger has been
reported to inhibit the rise in intracellular Na+
and to delay the rise in Ca2+ in cardiac
myocytes.31 To evaluate the possible involvement of the
Na+/H+ exchanger in our
experimental model of in vitro ischemia, we investigated the
effects of HMA, a blocker of this exchanger, on the OGD-induced
membrane depolarization. HMA (1 to 3 µmol/L) did not affect this
electrophysiological event in any of the
tested neurons. In fact, the OGD-induced depolarization was not
significantly altered by HMA (102±5%, n=10, P>0.05) (data
not shown).
| Discussion |
|---|
|
|
|---|
It has been shown that the Na+/Ca2+ exchanger becomes reversed during hypoxia,12 19 and there is a growing amount of literature on the role of this exchanger during energy deprivation in a variety of CNS tissue.7 32 Blockers of the Na+/Ca2+ exchanger afforded protection from anoxic injury in the rat optic nerve preparation.12 This protection was attributed, however, to a net reduction in intracellular Ca2+ due to the blockade of this exchanger. The authors argued that the anoxia-induced increase in intracellular Na+ concentration acts to reverse the driving force for the Na+/Ca2+ exchanger, thereby causing an increase in intracellular Ca2+. This increase caused neuronal injury and was inhibited by the blockade of the Na+/Ca2+ exchanger.
From our previous and current experiments, we propose a different interpretation of the role of this exchanger during OGD in spiny neurons. We suggest that the activation of the Na+/Ca2+ exchanger during the ischemic depolarization has a protective role, because we found that bepridil and DCB enhanced this electrophysiological event. Thus, we postulate that during OGD in striatal spiny neurons, as well as in optic nerve preparation, the rise in intracellular Na+ levels might force this exchanger to operate in a reverse mode (as a Na+ extruding system). However, in striatal spiny neurons, unlike in optic nerve preparation, the critical event for the OGD-induced injury is represented by the rise of intracellular Na+ rather than the intracellular increase of Ca2+. This conclusion contrasts with results from previous studies using other experimental models.33 In agreement with our findings, it has been recently reported that activation of the Na+/Ca2+ exchanger protects C6 glioma cells during chemical hypoxia.13 However, future studies in brain slices utilizing ion measurements of intracellular Ca2+ and Na+ are required to confirm this hypothesis. Unfortunately, at present, most of the drugs interfering with the activity of Na+/Ca2+ exchanger and Na+/H+ antiporter are amiloride derivatives, and their use is hampered by their autofluorescent properties.6 One should also consider the possibility that since glial cells are present in our preparation, they may play a role in the pharmacological effect we recorded from neuronal elements.
It has been shown that pharmacological inhibition of the Na+/Ca2+ exchanger enhances anoxia and glucopenia-induced release of EAAs in hippocampal slices.7 Thus, in the present study we have also addressed the possibility that the bepridil- and DCB-induced enhancement of the ischemic depolarization was due to an increased release of EAAs. The findings that these pharmacological effects were affected neither by TTX nor by antagonists of ionotropic glutamate receptors seems to rule out a presynaptic site of action of these drugs.
We have recently reported that L-type Ca2+ channels give a prominent contribution to both OGD-induced membrane depolarization and intracellular Ca2+ rise measured in cortical neurons.34 Thus, we have studied the possible involvement of these channels in the ischemic depolarization of striatal spiny neurons and in the facilitatory action of bepridil and DCB. The finding that nifedipine did not influence these latter parameters seems to exclude that L-type Ca2+ channels play a major role in the generation of this early ionic event and in its pharmacological modulation by blockers of Na+/Ca2+ exchanger.
We are aware that bepridil may cause effects other than inhibition of the Na+/Ca2+ exchanger.9 30 Thus, we have performed experiments with the amiloride derivative DCB, another inhibitor of the Na+/Ca2+ exchanger, and obtained similar results. The specificity of the effect of DCB on the Na+/Ca2+ activity was further supported by the lack of any effect on the ischemic depolarization exerted by HMA. This compound, although possessing a piperazine ring like DCB, is devoid of any inhibitory properties on the Na+/Ca2+ exchanger.35 In addition, because HMA has, at concentration of 1 µmol/L, Na+/H+ antiporter inhibitory properties,35 its failure to alter the ischemic depolarization seems to suggest that this antiporter is not involved in the mechanisms leading to this ionic event. It has been reported that bepridil and DCB might block K+ channels.36 Thus, it is possible that an interference of these compounds with K+ conductances might alter the OGD-induced depolarization. However, the latter possibility is unlikely, because bepridil and DCB at the concentrations used in this study do not affect the current-voltage relationship of the recorded cells.
The present study represents the first experimental attempt to compare the role of the Na+/Ca2+ exchanger during OGD and during the activation of ionotropic glutamate receptors in the same neuronal subtype. In hippocampal neurons, Ca2+ extrusion via the Na+/Ca2+ exchanger apparently plays an important role in the protection against neuronal excitotoxicity.37 Similar evidence for a protective role for the Na+/Ca2+ exchanger in glutamate neurotoxicity has also been obtained from studies in cerebellar granule cells.15 In these cells, pharmacological inhibitors of the exchanger strongly enhance glutamate-induced neuronal death. Another study, in the same neuronal subtypes, provided additional evidence in support of this hypothesis. Kiedrowski and colleagues14 demonstrated that glutamate pulses exhibit higher neurotoxicity than potassium pulses because of their greater capability to increase the intracellular Na+ concentration, which in turn impairs Ca2+ extrusion via the Na+/Ca2+ exchanger. In our experimental model we failed to detect a significant modulatory action of bepridil and DCB not only on the glutamate-mediated corticostriatal EPSPs whose amplitude and duration were much smaller than the ischemic depolarization, but also on the membrane responses induced by exogenous EAA agonists whose amplitude and duration mimicked the ischemic depolarization. Two explanations may account for this lack of effect. First, in our study we have evaluated the acute effect induced by EAAs (membrane depolarization) rather than the long-term morphological changes following excitotoxicity, which have been evaluated in most of the previous studies. It is possible that Ca2+ overload does not influence the acute EAA agonistinduced membrane depolarization while it plays a prominent role in the "delayed neuronal death." Second, under physiological conditions, the supply of ATP is not limited, and the Ca2+-ATPase would be capable of extruding most of the excess of Ca2+ admitted during the activation of ionotropic glutamate receptors. Moreover, the Na+/K+ ATP-dependent pump is able to provide an effective mechanism to limit excessive intracellular Na+ overload during the action of various EAAs.38 The activity of these 2 protective mechanisms is impaired during energy deprivation, because ATP production is dramatically reduced. Thus, in this physiopathological condition, the protective role of the Na+/Ca2+ exchanger operating in its reverse mode is unmasked. Finally, we would like to close this study with 2 notes of caution in the interpretation of the presented data. First, in our experimental model we have analyzed membrane depolarizations induced by OGD. It is commonly assumed that these depolarizations may ultimately lead to neuronal death; however, a morphological analysis of the tissue alterations induced by OGD in our model has not been performed. Second, our conclusions stands on in vitro data; future studies utilizing in vivo models of ischemia would be of great interest to further clarify the role of Na+/Ca2+ exchanger in this pathological event.
| Acknowledgments |
|---|
Received February 8, 1999; revision received April 14, 1999; accepted May 3, 1999.
| References |
|---|
|
|
|---|
2. Choi DW, Rothman SM. The role of glutamate neurotoxicity in hypoxic-ischemic neuronal death. Annu Rev Neurosci. 1990;13:171182.[Medline] [Order article via Infotrieve]
3. Friedman JE, Haddad GG. Removal of extracellular sodium prevents anoxia-induced injury in freshly dissociated rat CA1 hippocampal neurons. Brain Res. 1994;641:5764.[Medline] [Order article via Infotrieve]
4.
Calabresi P, Pisani A, Mercuri NB, Bernardi G. On the
mechanisms underlying hypoxia-induced membrane depolarization
in striatal neurons. Brain. 1995;118:10271038.
5. Friedman JE, Haddad GG. Anoxia induces an increase in intracellular sodium in rat central neurons in vitro. Brain Res. 1994;663:329334.[Medline] [Order article via Infotrieve]
6. Pisani A, Calabresi P, Tozzi A, Bernardi G, Knopfel. Early sodium elevations induced by combined oxygen and glucose deprivation in pyramidal cortical neurons. Eur J Neurosci. 1998;10:35723574.[Medline] [Order article via Infotrieve]
7.
Amoroso S, Sensi S, Di Renzo G, Annunziato L.
Inhibition of the Na+-Ca++
exchanger enhances anoxia and glucopenia-induced
[3H]aspartate release in hippocampal slices.
J Pharmacol Exp Ther. 1993;264:515520.
8. Benveniste H, Drejer J, Schousboe A, Diemer NH. Elevation of the extracellular concentration of glutamate and aspartate in the rat hippocampus during transient cerebral ischemia monitored by intracerebral microdialysis. J Neurosci. 1984;43:13691374.
9.
Steffensen I, Stys PK. The
Na+-Ca2+ exchanger in
neurons and glial cells. Neuroscientist.. 1996;2:162171.
10.
Sanchez-Armass S, Blaustein MP. Role of sodium-calcium
exchange in regulation of intracellular calcium in nerve terminals.
Am J Physiol. 1987;252:C595603.
11.
Mullins LJ. A mechanism for Na/Ca transport.
J Gen Physiol. 1977;70:681695.
12. Stys PK, Waxman SG, Ransom BR. Ionic mechanisms of anoxic injury in mammalian CNS white matter: role of Na+ channels and Na+-Ca2+ exchanger. J Neurosci. 1992;12:430439.[Abstract]
13. Amoroso S, De Maio M, Russo GM, Catalano A, Bassi A, Montagnani S, Di Renzo G, Annunziato L. Pharmacological evidence that the activation of the Na+-Ca2+ exchanger protects C6 glioma cells during chemical hypoxia. Br J Pharmacol. 1997;121:303309.[Medline] [Order article via Infotrieve]
14. Kiedrowski L, Brooker G, Costa E, Wroblewski JT. Glutamate impairs neuronal calcium extrusion while reducing sodium gradient. Neuron. 1994;12:295300.[Medline] [Order article via Infotrieve]
15. Andreeva N, Khodorov B, Stelmashook E, Cragoe E, Victorov I. Inhibition of Na+/Ca2+ exchange enhances delayed neuronal death elicited by glutamate in cerebellar granule cell cultures. Brain Res. 1991;548:322325.[Medline] [Order article via Infotrieve]
16. Pulsinelli WA. Selective neuronal vulnerability: morphological and molecular characteristics. Prog Brain Res. 1985;63:2937.[Medline] [Order article via Infotrieve]
17.
Calabresi P, Magarinos Ascone C, Centonze D, Pisani A,
Sancesario G, D'Angelo V, Bernardi G. Opposite membrane potential
changes induced by glucose deprivation in striatal spiny
neurons and in large spiny interneurons. J Neurosci. 1997;17:19401949.
18. Calabresi P, Centonze D, Pisani A, Sancesario G, Gubellini P, Marfia GA, Bernardi G. Striatal spiny neurons and cholinergic interneurons express differential ionotropic glutamatergic responses and vulnerability: implications for ischemia and Huntington's disease. Ann Neurol. 1998;43:586597.[Medline] [Order article via Infotrieve]
19. Waxman SG, Ransom BR, Stys PK. Non-synaptic mechanisms of calcium-mediated injury in CNS white matter. Trends Neurosci. 1991;14:461468.[Medline] [Order article via Infotrieve]
20.
Agrawal SK, Fehlings MG. Mechanisms of secondary injury
to spinal cord axons in vitro: role of Na+,
Na+-K+-ATPase, the
Na+-H+ exchanger, and the
Na+-Ca2+ exchanger.
J Neurosci. 1996;16:545552.
21. Lehning EJ, Doshi R, Isaksson N, Stys PK, LoPachin RM Jr. Mechanisms of injury-induced calcium entry into peripheral nerve myelinated axons: role of reverse sodium-calcium exchange. J Neurochem. 1996;66:493500.[Medline] [Order article via Infotrieve]
22. Wacholtz MC, Cragoe EJ Jr, Lipsky PE. Delineation of the role of a Na+/Ca2+ exchanger in regulating intracellular Ca2+ in T cells. Cell Immunol. 1993;147:95109.[Medline] [Order article via Infotrieve]
23.
Li L, van Breemen C.
Na+-Ca2+ exchange in intact
endothelium of rabbit cardiac valve. Circ
Res. 1995;76:396404.
24.
Monroe JJ, Tashjian AH Jr. Actions of palytoxin on
Na+ and Ca2+ homeostasis in
human osteoblast-like Saos-2 cells. Am J Physiol. 1995;269:C582C589.
25.
Shiraga M, Tomiyama Y, Honda S, Kashiwagi H, Kosugi S,
Handa M, Ikeda Y, Kanakura Y, Kurata Y, Matsuzawa Y. Affinity
modulation of the platelet integrin alpha IIb beta 3 by
alpha-chymotrypsin: a possible role for
Na+/Ca2+ exchanger.
Blood. 1996;88:25942602.
26.
Jiang Z-C, Haddad GG. Differential responses of
neocortical neurons to glucose and/or O2
deprivation in human and rat. J
Neurophysiol. 1992;68:21652173.
27. Horikawa H, Armstrong WE. A versatile means of intracellular labelling: injection of biocytin and its detection with avidin conjugates. J Neurosci Methods. 1988;25:111.[Medline] [Order article via Infotrieve]
28.
Calabresi P, Mercuri NB, Stefani A, Bernardi G.
Synaptic and intrinsic control of membrane excitability of neostriatal
neurons. I. An in vivo analysis. J
Neurophysiol. 1990;63:651662.
29.
Calabresi P, Marfia GA, Centonze D, Pisani A, Bernardi
G. Sodium influx plays a major role in the membrane depolarization
induced by oxygen and glucose deprivation in striatal spiny
neurons. Stroke. 1999;30:171179.
30. Sobolevsky A, Koshelev S, Khodorov BI. Bepridil-induced blockade of NMDA channels in rat hippocampal neurons. Neuropharmacology. 1997;36:319324.[Medline] [Order article via Infotrieve]
31.
Anderson SE, Murphy E, Steenbergen C, London R, Cala P.
Na-H exchange in myocardium: effects of hypoxia and
acidification on Na and Ca. Am J Physiol. 1990;259:C940C948.
32. Chidekel AS, Chow EJ, Friedman JE, Haddad GG. The role of Na+-dependent exchangers in anoxia-induced injury in rat neocortical neuronal culture. Am J Resp Crit Care Med. 1996;512:A639. Abstract.
33. Farooqui AA, Horrocks LA. Excitatory amino acid receptors, neuronal membrane phospholipid metabolism and neurological disorders. Brain Res Rev. 1991;16:171191.[Medline] [Order article via Infotrieve]
34.
Pisani A, Calabresi P, Tozzi A, D'Angelo V,
Bernardi G. L-type Ca2+ channel blockers
attenuate electrical changes and Ca2+ rise
induced by oxygen/glucose deprivation in cortical neurons.
Stroke. 1998;29:196201.
35. Simchowitz L, Cragoe JR. Inhibition of chemotactic factor-activated Na+-H+ exchange in human neutrophils by analogs of amiloride: structure-activity relationship in the amiloride series. Mol Pharmacol. 1986;30:11220.[Abstract]
36. Matsuda T, Takuma K, Baba A. Na+-Ca2+ exchanger: physiology and pharmacology. Jpn J Pharmacol. 1997;74:120.[Medline] [Order article via Infotrieve]
37. Mattson MP, Guthrie PB, Kater SB. A role for Na+-dependent Ca++ extrusion in protection against neuronal excitotoxicity. FASEB J. 1989;3:25192526.[Abstract]
38. Calabresi P, De Murtas M, Pisani A, Stefani A, Sancesario G, Mercuri NB, Bernardi G. Vulnerability of medium spiny striatal neurons to glutamate: role of Na+/K+ ATPase. Eur J Neurosci. 1995;7:16741683.[Medline] [Order article via Infotrieve]
Anesthesiology/Critical Care Medicine, Johns Hopkins Medical Institutions, Baltimore, Maryland
| Introduction |
|---|
|
|
|---|
Received February 8, 1999; revision received April 14, 1999; accepted May 3, 1999.
| References |
|---|
|
|
|---|
2.
Hoyt KR, Arden SR, Aizenman E, Reynolds IJ. Reverse
Na+/Ca2+ exchange contributes to
glutamate-induced intracellular Ca2+ concentration
increases in cultured rat forebrain neurons. Mol Pharmacol.. 1998;53:7429.
3. Schroeder UH, Breder J, Sabelhaus CF, Reymann KG. The novel Na+/Ca2+ exchange inhibitor KB-R7943 protects CA1 neurons in rat hippocampal slices against hypoxic/hypoglycemic injury. Neuropharmacol.. 1999;38:31921.[Medline] [Order article via Infotrieve]
4. DiPolo R, Beauge L. Metabolic pathways in the regulation of invertebrate and vertebrate Na+/Ca2+ exchange. Biochim Biophys Acta.. 1999;1422:5771.[Medline] [Order article via Infotrieve]
5. Stys PK. Anoxic and ischemic injury of myelinated axons in CNS white matter: from mechanistic concepts to therapeutics. J Cereb Blood Flow Metab.. 1998;18:225.[Medline] [Order article via Infotrieve]
This article has been cited by other articles:
![]() |
A. Tortiglione, B. Picconi, I. Barone, D. Centonze, S. Rossi, C. Costa, M. Di Filippo, A. Tozzi, M. Tantucci, G. Bernardi, et al. Na+/Ca2+ Exchanger Maintains Ionic Homeostasis in the Peri-Infarct Area Stroke, May 1, 2007; 38(5): 1614 - 1620. [Abstract] [Full Text] [PDF] |
||||
![]() |
L. Annunziato, G. Pignataro, and G. F. Di Renzo Pharmacology of Brain Na+/Ca2+ Exchanger: From Molecular Biology to Therapeutic Perspectives Pharmacol. Rev., December 1, 2004; 56(4): 633 - 654. [Abstract] [Full Text] [PDF] |
||||
![]() |
X. Zhang, M. Cheng, and S. K. Chintala Kainic Acid-Mediated Upregulation of Matrix Metalloproteinase-9 Promotes Retinal Degeneration Invest. Ophthalmol. Vis. Sci., July 1, 2004; 45(7): 2374 - 2383. [Abstract] [Full Text] [PDF] |
||||
![]() |
P. Calabresi, E. Saulle, D. Centonze, A. Pisani, G. A. Marfia, and G. Bernardi Post-ischaemic long-term synaptic potentiation in the striatum: a putative mechanism for cell type-specific vulnerability Brain, April 1, 2002; 125(4): 844 - 860. [Abstract] [Full Text] [PDF] |
||||
![]() |
D. Centonze, A. Pisani, P. Bonsi, P. Giacomini, G. Bernardi, and P. Calabresi Stimulation of Nitric Oxide-cGMP Pathway Excites Striatal Cholinergic Interneurons via Protein Kinase G Activation J. Neurosci., February 15, 2001; 21(4): 1393 - 1400. [Abstract] [Full Text] [PDF] |
||||
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
|
Stroke Home | Subscriptions | Archives | Feedback | Authors | Help | AHA Journals Home | Search Copyright © 1999 American Heart Association, Inc. All rights reserved. Unauthorized use prohibited. |